Results for Imatinib
Public health and IP in India: Novartis loses Gleevec patent appeal at the Supreme Court Public health and IP in India: Novartis loses Gleevec patent appeal at the Supreme Court Reviewed by Stefano Barazza on Wednesday, April 03, 2013 Rating: 5
Powered by Blogger.